Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
De Gruyter
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3f4e7162eaef4944881f5bd1d9ff437b |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients. |
|---|